InspireMD Inc reports results for the quarter ended June 30 - Earnings Summary

InspireMD

17/08/2026 14:32

InspireMD Inc NSPR.OQ reported a quarterly adjusted loss of 17 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -26 cents.  The mean expectation of three analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -21 cents to -19 cents per share.
Revenue fell 0.4% to $1.77 million from a year ago; analysts expected $1.38 million. 
InspireMD Inc's reported EPS for the quarter was a loss of 17 cents​.
The company reported a quarterly loss of $14.32 million.
InspireMD Inc shares had risen by 40.3% this quarter and lost 44.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for InspireMD Inc is $4.00, about 75.4% above its last closing price of $0.98
This summary was machine generated from LSEG data August 17 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.20
-0.17
Beat
Mar. 31 2026 
-0.18
-0.16
Beat
Dec. 31 2025 
-0.19
-0.14
Beat
Sep. 30 2025 
-0.19
-0.17
Beat